Ibisobanuro
Bromoacetonitrile cyangwa cyanomethyl bromide nuruvange rwinshi rufite akamaro kanini muguhuza ibiyobyabwenge.Isuku ryinshi nubwiza bwibicuruzwa byacu bituma biba byiza kubigo bikorerwamo ibya farumasi nibigo byubushakashatsi bishaka guteza imbere uburyo bushya bwo kuvura indwara zitandukanye.
Nkurwego rwingenzi hagati ya synthesis ya Paxlovid, bromoacetonitrile yacu igira uruhare runini mugukora uyu muti urokora ubuzima.Paxlovid azwi cyane kubera akamaro kayo mu kuvura abarwayi ba COVID-19, bizana ibyiringiro no gutabarwa ku banduye iki cyorezo.Mugutanga isoko yizewe, yujuje ubuziranenge ya bromoacetonitrile, twishimiye gutanga umusanzu mubikorwa byisi byo kurwanya virusi no kurokora ubuzima.
Bromoacetonitrile yacu ikorwa murwego rwohejuru rwinganda, itanga ubudahwema nubuziranenge kuva mubice kugeza kubandi.Twumva akamaro k'ubwiza no kwizerwa mu nganda zimiti, kandi twiyemeje gutanga ibicuruzwa byujuje kandi birenze ibyo abakiriya bacu bategereje.
Hitamo
JDK ifite ibikoresho byo mu rwego rwa mbere n’ibikoresho byo gucunga ubuziranenge, byizeza itangwa rihamye ry’abahuza API.Itsinda ryumwuga ryizeza R&D yibicuruzwa.Kurwanya byombi, turimo gushakisha CMO & CDMO kumasoko yimbere mu gihugu no mumahanga.
